TreeWAS – Variant ID: rs79019069

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter II Neoplasms	0.999	0.001
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.998	0.002
Chapter I Certain infectious and parasitic diseases	0.998	0.002
Chapter XII Diseases of the skin and subcutaneous tissue	0.996	0.004
B95-B98 Bacterial, viral and other infectious agents	0.994	0.006
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.992	0.008
C79 Secondary malignant neoplasm of other sites	0.989	0.011
L80-L99 Other disorders of the skin and subcutaneous tissue	0.985	0.015
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.985	0.015
Chapter XIV Diseases of the genitourinary system	0.973	0.027
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.970	0.030
L82 Seborrhoeic keratosis	0.956	0.044
N17-N19 Renal failure	0.952	0.048
Chapter IV Endocrine, nutritional and metabolic diseases	0.952	0.048
C64-C68 Malignant neoplasms of urinary tract	0.951	0.049
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.948	0.052
N18 Chronic renal failure	0.944	0.056
L90 Atrophic disorders of skin	0.941	0.059
D37-D48 Neoplasms of uncertain or unknown behaviour	0.941	0.059
Chapter XXII Codes for special purposes	0.936	0.064
Chapter V Mental and behavioural disorders	0.926	0.074
N18.3 Chronic kidney disease, stage 3	0.925	0.075
L90.5 Scar conditions and fibrosis of skin	0.920	0.080
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.920	0.080
N10-N16 Renal tubulo-interstitial diseases	0.913	0.087
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.911	0.089
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis	0.911	0.089
N30-N39 Other diseases of urinary system	0.899	0.101
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.892	0.108
C77.3 Axillary and upper limb lymph nodes	0.892	0.108
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.890	0.110
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.890	0.110
L40-L45 Papulosquamous disorders	0.884	0.116
C64 Malignant neoplasm of kidney, except renal pelvis	0.882	0.118
E10-E14 Diabetes mellitus	0.879	0.121
R91 Abnormal findings on diagnostic imaging of lung	0.878	0.122
N32 Other disorders of bladder	0.874	0.126
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.870	0.130
N25-N29 Other disorders of kidney and ureter	0.870	0.130
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.869	0.131
E20-E35 Disorders of other endocrine glands	0.864	0.136
N32.8 Other specified disorders of bladder	0.851	0.149
D41.4 Bladder	0.848	0.152
R93 Abnormal findings on diagnostic imaging of other body structures	0.846	0.154
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.838	0.162
C78.0 Secondary malignant neoplasm of lung	0.837	0.163
C77.0 Lymph nodes of head, face and neck	0.835	0.165
L50-L54 Urticaria and erythema	0.834	0.166
F40-F48 Neurotic, stress-related and somatoform disorders	0.830	0.170
E10 Insulin-dependent diabetes mellitus	0.826	0.174
B35-B49 Mycoses	0.825	0.175
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.824	0.176
A30-A49 Other bacterial diseases	0.823	0.177
C79.8 Secondary malignant neoplasm of other specified sites	0.820	0.180
C67 Malignant neoplasm of bladder	0.816	0.184
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.811	0.189
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.811	0.189
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.802	0.198
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.800	0.200
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.800	0.200
U80 Agent resistant to penicillin and related antibiotics	0.798	0.202
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.797	0.203
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.796	0.204
N28 Other disorders of kidney and ureter, not elsewhere classified	0.796	0.204
Q60-Q64 Congenital malformations of the urinary system	0.795	0.205
E70-E90 Metabolic disorders	0.794	0.206
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.793	0.207
B15-B19 Viral hepatitis	0.792	0.208
L40 Psoriasis	0.788	0.212
D00-D09 In situ neoplasms	0.788	0.212
N18.9 Chronic renal failure, unspecified	0.784	0.216
N18.0 End-stage renal disease	0.784	0.216
B90-B94 Sequelae of infectious and parasitic diseases	0.782	0.218
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.782	0.218
R47-R49 Symptoms and signs involving speech and voice	0.780	0.220
L92 Granulomatous disorders of skin and subcutaneous tissue	0.779	0.221
S70-S79 Injuries to the hip and thigh	0.775	0.225
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.771	0.229
L60-L75 Disorders of skin appendages	0.769	0.231
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.769	0.231
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.764	0.236
S40-S49 Injuries to the shoulder and upper arm	0.762	0.238
C80 Malignant neoplasm without specification of site	0.762	0.238
L95 Vasculitis limited to skin, not elsewhere classified	0.760	0.240
F00-F09 Organic, including symptomatic, mental disorders	0.760	0.240
C79.6 Secondary malignant neoplasm of ovary	0.757	0.243
L81 Other disorders of pigmentation	0.757	0.243
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.752	0.248
N30 Cystitis	0.749	0.251
E14 Unspecified diabetes mellitus	0.745	0.255
S20-S29 Injuries to the thorax	0.744	0.256
R26 Abnormalities of gait and mobility	0.742	0.258
L89 Decubitus ulcer	0.741	0.258
N11 Chronic tubulo-interstitial nephritis	0.741	0.259
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.738	0.261
N13 Obstructive and reflux uropathy	0.736	0.264
C77.8 Lymph nodes of multiple regions	0.735	0.265
L00-L08 Infections of the skin and subcutaneous tissue	0.735	0.265
F43 Reaction to severe stress, and adjustment disorders	0.734	0.266
C77.4 Inguinal and lower limb lymph nodes	0.734	0.266
E10.9 Without complications	0.733	0.267
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.730	0.270
Chapter XX External causes of morbidity and mortality	0.724	0.276
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.723	0.277
N28.1 Cyst of kidney, acquired	0.721	0.279
R94 Abnormal results of function studies	0.718	0.282
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.718	0.282
N18.4 Chronic kidney disease, stage 4	0.718	0.282
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.716	0.284
C40-C41 Malignant neoplasms of bone and articular cartilage	0.716	0.284
C76 Malignant neoplasm of other and ill-defined sites	0.716	0.284
L85 Other epidermal thickening	0.716	0.284
B99-B99 Other infectious diseases	0.716	0.284
B85-B89 Pediculosis, acariasis and other infestations	0.716	0.284
B65-B83 Helminthiases	0.716	0.284
B50-B64 Protozoal diseases	0.716	0.284
B20-B24 Human immunodeficiency virus [HIV] disease	0.716	0.284
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.716	0.284
A80-A89 Viral infections of the central nervous system	0.716	0.284
A75-A79 Rickettsioses	0.716	0.284
A70-A74 Other diseases caused by chlamydiae	0.716	0.284
A65-A69 Other spirochaetal diseases	0.716	0.284
A20-A28 Certain zoonotic bacterial diseases	0.716	0.284
A15-A19 Tuberculosis	0.716	0.284
F17 Mental and behavioural disorders due to use of tobacco	0.715	0.285
L10-L14 Bullous disorders	0.714	0.286
T20-T25 Burns and corrosions of external body surface, specified by site	0.713	0.287
N10 Acute tubulo-interstitial nephritis	0.713	0.287
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.712	0.288
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.711	0.289
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.711	0.289
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.711	0.289
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.710	0.290
C79.7 Secondary malignant neoplasm of adrenal gland	0.709	0.291
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.709	0.291
C79.2 Secondary malignant neoplasm of skin	0.709	0.291
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.709	0.291
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.709	0.291
C67.9 Bladder, unspecified	0.709	0.291
N18.2 Chronic kidney disease, stage 2	0.708	0.291
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.707	0.293
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.706	0.294
L94 Other localised connective tissue disorders	0.706	0.294
L93 Lupus erythematosus	0.706	0.294
L87 Transepidermal elimination disorders	0.706	0.294
L88 Pyoderma gangrenosum	0.706	0.294
L86 Keratoderma in diseases classified elsewhere	0.706	0.294
L83 Acanthosis nigricans	0.706	0.294
L80 Vitiligo	0.706	0.294
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.706	0.294
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.704	0.295
U51 Admission status on psychiatric patients	0.704	0.296
B37 Candidiasis	0.701	0.299
S90-S99 Injuries to the ankle and foot	0.697	0.303
U80.0 Penicillin resistant agent	0.696	0.303
Q61 Cystic kidney disease	0.696	0.304
D46 Myelodysplastic syndromes	0.695	0.305
S10-S19 Injuries to the neck	0.693	0.307
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.693	0.307
C34 Malignant neoplasm of bronchus and lung	0.693	0.307
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.692	0.307
D41.0 Kidney	0.692	0.308
E20 Hypoparathyroidism	0.690	0.310
F41 Other anxiety disorders	0.689	0.311
E10.0 With coma	0.688	0.312
R26.8 Other and unspecified abnormalities of gait and mobility	0.687	0.313
R80 Isolated proteinuria	0.685	0.315
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.685	0.315
N28.9 Disorder of kidney and ureter, unspecified	0.685	0.315
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.685	0.315
S72 Fracture of femur	0.683	0.317
A50-A64 Infections with a predominantly sexual mode of transmission	0.683	0.317
L20-L30 Dermatitis and eczema	0.683	0.317
C68 Malignant neoplasm of other and unspecified urinary organs	0.682	0.318
C66 Malignant neoplasm of ureter	0.682	0.318
C65 Malignant neoplasm of renal pelvis	0.682	0.318
U80.1 Methicillin resistant agent	0.680	0.320
E23 Hypofunction and other disorders of pituitary gland	0.679	0.321
E40-E46 Malnutrition	0.677	0.323
N18.8 Other chronic renal failure	0.677	0.323
N18.1 Chronic kidney disease, stage 1	0.677	0.323
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.675	0.324
C73 Malignant neoplasm of thyroid gland	0.676	0.324
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.675	0.325
C78.2 Secondary malignant neoplasm of pleura	0.675	0.325
L90.9 Atrophic disorder of skin, unspecified	0.675	0.325
L90.8 Other atrophic disorders of skin	0.675	0.325
L90.6 Striae atrophicae	0.675	0.325
L90.4 Acrodermatitis chronica atrophicans	0.675	0.325
L90.3 Atrophoderma of Pasini and Pierini	0.675	0.325
L90.2 Anetoderma of Jadassohn-Pellizzari	0.675	0.325
L90.1 Anetoderma of Schweninger-Buzzi	0.675	0.325
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.675	0.325
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.675	0.325
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.675	0.325
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.675	0.325
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.675	0.325
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.675	0.325
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.675	0.325
L43 Lichen planus	0.674	0.326
T92 Sequelae of injuries of upper limb	0.673	0.327
L97 Ulcer of lower limb, not elsewhere classified	0.673	0.327
F60-F69 Disorders of adult personality and behaviour	0.672	0.327
C77.1 Intrathoracic lymph nodes	0.672	0.328
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.672	0.328
M70-M79 Other soft tissue disorders	0.672	0.328
B97 Viral agents as the cause of diseases classified to other chapters	0.671	0.329
D45 Polycythaemia vera	0.670	0.330
E86 Volume depletion	0.670	0.330
L52 Erythema nodosum	0.669	0.331
E83 Disorders of mineral metabolism	0.669	0.331
Q50-Q56 Congenital malformations of genital organs	0.669	0.331
E27 Other disorders of adrenal gland	0.668	0.332
L53 Other erythematous conditions	0.668	0.332
A41 Other septicaemia	0.667	0.333
A00-A09 Intestinal infectious diseases	0.664	0.336
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.664	0.336
F80-F89 Disorders of psychological development	0.664	0.336
F70-F79 Mental retardation	0.664	0.336
N32.3 Diverticulum of bladder	0.663	0.337
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.661	0.339
R95-R99 Ill-defined and unknown causes of mortality	0.659	0.341
S80-S89 Injuries to the knee and lower leg	0.659	0.341
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.659	0.341
F17.2 Dependence syndrome	0.658	0.342
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.657	0.342
L72 Follicular cysts of skin and subcutaneous tissue	0.657	0.343
M65-M68 Disorders of synovium and tendon	0.657	0.343
L40.9 Psoriasis, unspecified	0.657	0.343
R25 Abnormal involuntary movements	0.655	0.345
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.655	0.345
N15 Other renal tubulo-interstitial diseases	0.655	0.345
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.655	0.345
Q00-Q07 Congenital malformations of the nervous system	0.655	0.345
N99-N99 Other disorders of the genitourinary system	0.654	0.345
B25-B34 Other viral diseases	0.653	0.347
L91 Hypertrophic disorders of skin	0.653	0.347
T79-T79 Certain early complications of trauma	0.653	0.347
T33-T35 Frostbite	0.653	0.347
T26-T28 Burns and corrosions confined to eye and internal organs	0.653	0.347
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.653	0.347
T00-T07 Injuries involving multiple body regions	0.653	0.347
R92 Abnormal findings on diagnostic imaging of breast	0.653	0.347
N18.5 Chronic kidney disease, stage 5	0.653	0.347
E50-E64 Other nutritional deficiencies	0.652	0.348
S60-S69 Injuries to the wrist and hand	0.651	0.349
R47 Speech disturbances, not elsewhere classified	0.650	0.350
C79.9 Secondary malignant neoplasm, unspecified site	0.650	0.350
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.650	0.350
C32 Malignant neoplasm of larynx	0.650	0.350
M50-M54 Other dorsopathies	0.649	0.351
D05 Carcinoma in situ of breast	0.648	0.352
E65-E68 Obesity and other hyperalimentation	0.647	0.353
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.646	0.354
N37 Urethral disorders in diseases classified elsewhere	0.645	0.355
N34 Urethritis and urethral syndrome	0.645	0.355
N33 Bladder disorders in diseases classified elsewhere	0.645	0.355
B18 Chronic viral hepatitis	0.644	0.356
T15-T19 Effects of foreign body entering through natural orifice	0.643	0.357
N13.9 Obstructive and reflux uropathy, unspecified	0.641	0.359
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.641	0.359
B37.8 Candidiasis of other sites	0.641	0.359
D41.9 Urinary organ, unspecified	0.640	0.360
D41.7 Other urinary organs	0.640	0.360
D41.3 Urethra	0.640	0.360
D41.2 Ureter	0.640	0.360
D41.1 Renal pelvis	0.640	0.360
N32.0 Bladder-neck obstruction	0.640	0.360
T88 Other complications of surgical and medical care, not elsewhere classified	0.639	0.361
L40.5 Arthropathic psoriasis	0.639	0.361
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.638	0.362
Q80-Q89 Other congenital malformations	0.638	0.362
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.638	0.362
Q35-Q37 Cleft lip and cleft palate	0.638	0.362
Q30-Q34 Congenital malformations of the respiratory system	0.638	0.362
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.638	0.362
Q38-Q45 Other congenital malformations of the digestive system	0.637	0.363
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract	0.637	0.363
R90 Abnormal findings on diagnostic imaging of central nervous system	0.635	0.365
N30.9 Cystitis, unspecified	0.635	0.365
L44 Other papulosquamous disorders	0.634	0.366
L41 Parapsoriasis	0.634	0.366
L45 Papulosquamous disorders in diseases classified elsewhere	0.634	0.366
L42 Pityriasis rosea	0.634	0.366
Q20-Q28 Congenital malformations of the circulatory system	0.633	0.366
E10.5 With peripheral circulatory complications	0.633	0.367
F03 Unspecified dementia	0.633	0.367
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.632	0.368
E21.3 Hyperparathyroidism, unspecified	0.631	0.368
E13 Other specified diabetes mellitus	0.630	0.370
E12 Malnutrition-related diabetes mellitus	0.630	0.370
Q60 Renal agenesis and other reduction defects of kidney	0.629	0.371
E14.9 Without complications	0.628	0.372
M05-M14 Inflammatory polyarthropathies	0.628	0.372
U89 Agent resistant to other and unspecified antibiotics	0.627	0.373
B91 Sequelae of poliomyelitis	0.627	0.373
N32.4 Rupture of bladder, nontraumatic	0.626	0.374
N32.2 Vesical fistula, not elsewhere classified	0.626	0.374
N32.1 Vesicointestinal fistula	0.626	0.374
F99-F99 Unspecified mental disorder	0.625	0.375
M86-M90 Other osteopathies	0.624	0.376
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.624	0.376
C78.4 Secondary malignant neoplasm of small intestine	0.624	0.376
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.624	0.376
C78.1 Secondary malignant neoplasm of mediastinum	0.624	0.376
C51-C58 Malignant neoplasms of female genital organs	0.624	0.376
N29 Other disorders of kidney and ureter in diseases classified elsewhere	0.623	0.376
N27 Small kidney of unknown cause	0.623	0.376
N25 Disorders resulting from impaired renal tubular function	0.623	0.376
N26 Unspecified contracted kidney	0.623	0.376
U81 Agent resistant to vancomycin and related antibiotics	0.623	0.377
U50 Level of care administered to neonates	0.623	0.377
U07 Emergency use of U07	0.623	0.377
U06 Emergency use of U06	0.623	0.377
U04 Severe acute respiratory syndrome [SARS]	0.623	0.377
U52 First in a series of a regular day/night admissions	0.623	0.377
F41.2 Mixed anxiety and depressive disorder	0.623	0.377
E88 Other metabolic disorders	0.623	0.377
N19 Unspecified renal failure	0.622	0.378
N32.9 Bladder disorder, unspecified	0.622	0.378
E10.4 With neurological complications	0.621	0.379
N36 Other disorders of urethra	0.620	0.379
E35 Disorders of endocrine glands in diseases classified elsewhere	0.620	0.380
E34 Other endocrine disorders	0.620	0.380
E32 Diseases of thymus	0.620	0.380
E31 Polyglandular dysfunction	0.620	0.380
E30 Disorders of puberty, not elsewhere classified	0.620	0.380
E29 Testicular dysfunction	0.620	0.380
E26 Hyperaldosteronism	0.620	0.380
E25 Adrenogenital disorders	0.620	0.380
E24 Cushing's syndrome	0.620	0.380
C49 Malignant neoplasm of other connective and soft tissue	0.619	0.381
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.618	0.382
M91-M94 Chondropathies	0.617	0.383
F43.2 Adjustment disorders	0.616	0.384
R94.5 Abnormal results of liver function studies	0.616	0.384
D07 Carcinoma in situ of other and unspecified genital organs	0.615	0.384
L40.0 Psoriasis vulgaris	0.614	0.385
S22 Fracture of rib(s), sternum and thoracic spine	0.614	0.385
A49 Bacterial infection of unspecified site	0.613	0.387
A46 Erysipelas	0.613	0.387
C77.9 Lymph node, unspecified	0.611	0.389
N30.2 Other chronic cystitis	0.611	0.389
E22 Hyperfunction of pituitary gland	0.611	0.389
R82 Other abnormal findings in urine	0.610	0.390
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.610	0.390
R49 Voice disturbances	0.610	0.390
N13.6 Pyonephrosis	0.609	0.391
R81 Glycosuria	0.609	0.391
E28 Ovarian dysfunction	0.608	0.392
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.608	0.392
N00-N08 Glomerular diseases	0.607	0.393
R93.6 Abnormal findings on diagnostic imaging of limbs	0.606	0.393
L72.1 Trichilemmal cyst	0.606	0.394
T90 Sequelae of injuries of head	0.602	0.398
M60-M63 Disorders of muscles	0.601	0.399
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.601	0.399
C38 Malignant neoplasm of heart, mediastinum and pleura	0.601	0.399
C31 Malignant neoplasm of accessory sinuses	0.601	0.399
C30 Malignant neoplasm of nasal cavity and middle ear	0.601	0.399
C37 Malignant neoplasm of thymus	0.601	0.399
C33 Malignant neoplasm of trachea	0.601	0.399
C81 Hodgkin's disease	0.599	0.401
C67.4 Posterior wall of bladder	0.599	0.401
L95.9 Vasculitis limited to skin, unspecified	0.598	0.401
L54 Erythema in diseases classified elsewhere	0.598	0.402
L51 Erythema multiforme	0.598	0.402
L50 Urticaria	0.598	0.402
L89.9 Decubitus ulcer and pressure area, unspecified	0.596	0.403
E10.3 With ophthalmic complications	0.596	0.404
F48 Other neurotic disorders	0.595	0.405
F45 Somatoform disorders	0.595	0.405
F44 Dissociative [conversion] disorders	0.595	0.405
F42 Obsessive-compulsive disorder	0.595	0.405
F43.0 Acute stress reaction	0.595	0.405
E10.1 With ketoacidosis	0.595	0.405
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.595	0.405
C67.2 Lateral wall of bladder	0.594	0.406
S42 Fracture of shoulder and upper arm	0.593	0.407
S40 Superficial injury of shoulder and upper arm	0.593	0.407
E10.8 With unspecified complications	0.592	0.408
E10.7 With multiple complications	0.592	0.408
E10.6 With other specified complications	0.592	0.408
E10.2 With renal complications	0.592	0.408
B48 Other mycoses, not elsewhere classified	0.592	0.408
B47 Mycetoma	0.592	0.408
B46 Zygomycosis	0.592	0.408
B45 Cryptococcosis	0.592	0.408
B44 Aspergillosis	0.592	0.408
B43 Chromomycosis and phaeomycotic abscess	0.592	0.408
B42 Sporotrichosis	0.592	0.408
B41 Paracoccidioidomycosis	0.592	0.408
B40 Blastomycosis	0.592	0.408
B39 Histoplasmosis	0.592	0.408
B38 Coccidioidomycosis	0.592	0.408
B36 Other superficial mycoses	0.592	0.408
B35 Dermatophytosis	0.592	0.408
B49 Unspecified mycosis	0.592	0.408
N30.3 Trigonitis	0.592	0.408
C77.5 Intrapelvic lymph nodes	0.591	0.409
A48 Other bacterial diseases, not elsewhere classified	0.590	0.410
A44 Bartonellosis	0.590	0.410
A43 Nocardiosis	0.590	0.410
A42 Actinomycosis	0.590	0.410
A40 Streptococcal septicaemia	0.590	0.410
A39 Meningococcal infection	0.590	0.410
A37 Whooping cough	0.590	0.410
A36 Diphtheria	0.590	0.410
A32 Listeriosis	0.590	0.410
A31 Infection due to other mycobacteria	0.590	0.410
A30 Leprosy [Hansen's disease]	0.590	0.410
A38 Scarlet fever	0.590	0.410
A35 Other tetanus	0.590	0.410
A34 Obstetrical tetanus	0.590	0.410
A33 Tetanus neonatorum	0.590	0.410
Q63 Other congenital malformations of kidney	0.589	0.410
L81.9 Disorder of pigmentation, unspecified	0.588	0.412
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.587	0.413
M80-M85 Disorders of bone density and structure	0.587	0.413
U51.1 Previously admitted to a psychiatric hospital of the provider	0.585	0.414
C67.8 Overlapping lesion of bladder	0.585	0.415
C67.7 Urachus	0.585	0.415
C67.6 Ureteric orifice	0.585	0.415
C67.5 Bladder neck	0.585	0.415
C67.3 Anterior wall of bladder	0.585	0.415
C67.1 Dome of bladder	0.585	0.415
C67.0 Trigone of bladder	0.585	0.415
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.585	0.415
M00-M03 Infectious arthropathies	0.585	0.415
S50-S59 Injuries to the elbow and forearm	0.583	0.417
C75 Malignant neoplasm of other endocrine glands and related structures	0.581	0.419
C74 Malignant neoplasm of adrenal gland	0.581	0.419
U80.8 Agent resistant to other penicillin-related antibiotic	0.581	0.419
R23 Other skin changes	0.581	0.419
T92.2 Sequelae of fracture at wrist and hand level	0.579	0.421
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.578	0.421
C80.9 Malignant neoplasm, unspecified	0.578	0.422
F00 Dementia in Alzheimer's disease	0.578	0.422
T80 Complications following infusion, transfusion and therapeutic injection	0.575	0.425
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.575	0.425
N31.8 Other neuromuscular dysfunction of bladder	0.575	0.425
R25.2 Cramp and spasm	0.574	0.426
E14.3 With ophthalmic complications	0.572	0.428
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.572	0.428
F18 Mental and behavioural disorders due to use of volatile solvents	0.572	0.428
F16 Mental and behavioural disorders due to use of hallucinogens	0.572	0.428
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.572	0.428
F14 Mental and behavioural disorders due to use of cocaine	0.572	0.428
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.572	0.428
F12 Mental and behavioural disorders due to use of cannabinoids	0.572	0.428
F11 Mental and behavioural disorders due to use of opioids	0.572	0.428
T23 Burn and corrosion of wrist and hand	0.571	0.429
N28.0 Ischaemia and infarction of kidney	0.570	0.429
Q64 Other congenital malformations of urinary system	0.570	0.430
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.570	0.430
M45-M49 Spondylopathies	0.570	0.430
T86 Failure and rejection of transplanted organs and tissues	0.570	0.430
E85 Amyloidosis	0.570	0.430
E84 Cystic fibrosis	0.570	0.430
E79 Disorders of purine and pyrimidine metabolism	0.570	0.430
E77 Disorders of glycoprotein metabolism	0.570	0.430
E76 Disorders of glycosaminoglycan metabolism	0.570	0.430
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.570	0.430
E74 Other disorders of carbohydrate metabolism	0.570	0.430
E73 Lactose intolerance	0.570	0.430
E72 Other disorders of amino-acid metabolism	0.570	0.430
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.570	0.430
E70 Disorders of aromatic amino-acid metabolism	0.570	0.430
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.570	0.430
S49 Other and unspecified injuries of shoulder and upper arm	0.569	0.431
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.569	0.431
E83.5 Disorders of calcium metabolism	0.568	0.432
B19 Unspecified viral hepatitis	0.568	0.432
B17 Other acute viral hepatitis	0.568	0.432
B16 Acute hepatitis B	0.568	0.432
B15 Acute hepatitis A	0.568	0.432
C77.2 Intra-abdominal lymph nodes	0.567	0.433
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.567	0.433
E20.9 Hypoparathyroidism, unspecified	0.566	0.434
L40.8 Other psoriasis	0.565	0.435
L40.4 Guttate psoriasis	0.565	0.435
L40.3 Pustulosis palmaris et plantaris	0.565	0.435
L40.2 Acrodermatitis continua	0.565	0.435
L40.1 Generalised pustular psoriasis	0.565	0.435
D09 Carcinoma in situ of other and unspecified sites	0.565	0.435
D04 Carcinoma in situ of skin	0.565	0.435
D02 Carcinoma in situ of middle ear and respiratory system	0.565	0.435
D01 Carcinoma in situ of other and unspecified digestive organs	0.565	0.435
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.565	0.435
C80.0 Malignant neoplasm, primary site unknown, so stated	0.563	0.437
S72.0 Fracture of neck of femur	0.563	0.437
L90.0 Lichen sclerosus et atrophicus	0.562	0.438
D05.1 Intraductal carcinoma in situ	0.562	0.438
D48.5 Skin	0.561	0.439
M10 Gout	0.561	0.439
B94 Sequelae of other and unspecified infectious and parasitic diseases	0.560	0.439
B90 Sequelae of tuberculosis	0.560	0.439
B92 Sequelae of leprosy	0.560	0.439

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations